申请人:REILLY Usa
公开号:US20120232083A1
公开(公告)日:2012-09-13
The present invention is directed to a new class of hydroxamic acid derivatives, their use as LpxC inhibitors and, more specifically, their use to treat bacterial infections.
本发明涉及一种新型羟羧酸衍生物的类别,其作为LpxC抑制剂的用途,更具体地说,其用于治疗细菌感染。